Publications by authors named "Mark Zavrtanik"
Atrioesophageal fistula is one of the most feared complications of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) as it is associated with high mortality. Determining the esophagus location during RFCA might reduce the risk of esophageal injury. The present study aims to evaluate the feasibility of using intracardiac echocardiography integrated into a 3-dimensional electroanatomical mapping system (ICE/3D EAM) for the assessment of esophageal position and shifts in response to ablation.
View Article and Find Full Text PDFArticle Synopsis
- Lipoprotein(a) (Lp(a)) has been recognized as a significant risk factor for coronary artery disease and has gained attention recently due to the development of effective treatments.
- Lp(a) levels are primarily determined by genetics and have various harmful roles in the body, including promoting atherosclerosis and inflammation.
- Currently, the only proven treatment to effectively lower Lp(a) is through PCSK9 inhibitors, while future drug and gene-based therapies are being researched to reduce cardiovascular risks associated with high Lp(a) levels.